Monica Mallampalli
@mmallampalli1
โ ๏ธ With #Tirzepatide now approved for #OSA in #Obesity, beware of risks from compounded versions. FDA reports 320+ adverse events from unregulated formulations. Always verify sources & monitor AHI post-#WeightLoss. bit.ly/41XkyhH #GLP1 Monica Mallampalli